<VariationArchive RecordType="classified" VariationID="2627618" VariationName="NM_018941.4(CLN8):c.424dup (p.Ala142fs)" VariationType="Duplication" Accession="VCV002627618" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-04" DateCreated="2023-11-04" MostRecentSubmission="2023-11-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2795134" VariationID="2627618">
      <GeneList>
        <Gene Symbol="CLN8" FullName="CLN8 transmembrane ER and ERGIC protein" GeneID="2055" HGNC_ID="HGNC:2079" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="1753059" stop="1786570" display_start="1753059" display_stop="1786570" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NT_187680.1" start="165717" stop="199228" display_start="165717" display_stop="199228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="1711869" stop="1734735" display_start="1711869" display_stop="1734735" Strand="+" />
          </Location>
          <OMIM>607837</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018941.4(CLN8):c.424dup (p.Ala142fs)</Name>
      <CanonicalSPDI>NC_000008.11:1771477:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="1771477" stop="1771478" display_start="1771477" display_stop="1771478" variantLength="1" positionVCF="1771477" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="1719643" stop="1719644" display_start="1719643" display_stop="1719644" variantLength="1" positionVCF="1719643" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>A142fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_691" sequenceAccession="LRG_691">
            <Expression>LRG_691:g.20701dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_691t1" sequenceAccession="LRG_691t1">
            <Expression>LRG_691t1:c.424dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_691p1" sequenceAccession="LRG_691p1" change="p.Ala142Glyfs">
            <Expression>LRG_691p1:p.Ala142Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.1719644dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.1719644dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.1771478dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.1771478dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008656.2" sequenceAccession="NG_008656" sequenceVersion="2" change="g.20701dup">
            <Expression>NG_008656.2:g.20701dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018941.4" sequenceAccession="NM_018941" sequenceVersion="4" change="c.424dup" MANESelect="true">
            <Expression>NM_018941.4:c.424dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061764.2" sequenceAccession="NP_061764" sequenceVersion="2" change="p.Ala142fs">
            <Expression>NP_061764.2:p.Ala142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018941.4(CLN8):c.424dup (p.Ala142fs) AND Neuronal ceroid lipofuscinosis 8" Accession="RCV003388908" Version="1">
        <ClassifiedConditionList TraitSetID="721">
          <ClassifiedCondition DB="MedGen" ID="C1838570">Neuronal ceroid lipofuscinosis 8</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-11-04" MostRecentSubmission="2023-11-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="721" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4774" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 8</ElementValue>
                <XRef ID="MONDO:0010830" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLN8-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLN8</ElementValue>
                <XRef Type="MIM" ID="600143" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17152" />
                <XRef ID="17152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="168491" DB="Orphanet" />
              <XRef ID="228354" DB="Orphanet" />
              <XRef ID="79264" DB="Orphanet" />
              <XRef ID="C1838570" DB="MedGen" />
              <XRef ID="MONDO:0010830" DB="MONDO" />
              <XRef Type="MIM" ID="600143" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7679946" SubmissionDate="2023-11-01" DateLastUpdated="2023-11-04" DateCreated="2023-11-04">
        <ClinVarSubmissionID localKey="SUB13941005" submittedAssembly="GRCh38" title="SUB13941005" />
        <ClinVarAccession Accession="SCV004100685" DateUpdated="2023-11-04" DateCreated="2023-11-04" Type="SCV" Version="1" SubmitterName="Human Genome Lab, NIMHANS, National Institute of Mental Health and Neuro Sciences" OrgID="508696" OrganizationCategory="laboratory" OrgAbbreviation="HGL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift duplication NM_018941.4:c.424dup has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The NP_061764.2:p.Ala142Glyfs*105 variant is novel (not in any individuals) in 1000 Genomes, in gnomAD as well as in our inhouse database. This variant is predicted to cause loss of normal protein function through protein truncation caused by the frameshift mutation or such an mRNA is predicted to undergo nonsense mediated decay. The frame shifted sequence continues 105 residues until a stop codon is reached. This variant is a frameshift variant which occurs in an exon of CLN8 upstream of where nonsense mediated decay is predicted to occur. There are 18 downstream pathogenic loss of function variants, with the furthest variant being 121 residues downstream of this variant. This indicates that the region is critical to protein function. The p.Ala142Glyfs*105variant is a loss of function variant in the gene CLN8, which is intolerant of Loss of Function variants, as indicated by the presence of existing pathogenic loss of function variant NP_061764.2:p.S10* and 15 others. In addition, the patient's clinical phenotype matches with that of the disorder caused by pathogenic variants in CLN8 gene. For these reasons, this variant has been classified as Pathogenic (PM2 PVS1 PP4_Strong).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>South Indian Hindu</Ethnicity>
              <GeographicOrigin>South India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002376" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001336" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000648" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001251" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003205" />
              </Trait>
            </TraitSet>
            <Comment>A 4-year-old boy presented with developmental delay, seizures, regression of attained milestones, myoclonus, optic atrophy and ataxia. EEG showed diffuse slowing of background rhythm. MRI brain showed mild cerebellar volume loss, with T2 hyperintensities in posterior periventricular white matter- suggestive of NCL. Axillary skin biopsy showed distinctive membrane-bound curvilinear inclusions and fingerprint profiles in epithelial cells of glands. The NM_018941.4:c.424dup variant has been observed in homozygous state in this individual, confirming the diagnosis of Ceroid lipofuscinosis, neuronal, 8 (OMIM: 600143).</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN8">
              <Name>CLN8 transmembrane ER and ERGIC protein</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_018941.4:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">NM_018941.4:c.424dupG</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.11:g.1771478_1771479insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600143" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13941005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001251" MappingRef="HP">
        <MedGen CUI="C0007758" Name="Cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003205" MappingRef="HP">
        <MedGen CUI="C1836852" Name="Curvilinear intracellular accumulation of autofluorescent lipopigment storage material" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002376" MappingRef="HP">
        <MedGen CUI="C1836830" Name="Developmental regression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Disease" MappingType="XRef" MappingValue="600143" MappingRef="OMIM">
        <MedGen CUI="C1838570" Name="Neuronal ceroid lipofuscinosis 8" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000648" MappingRef="HP">
        <MedGen CUI="C0029124" Name="Optic atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679946" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001336" MappingRef="HP">
        <MedGen CUI="C0027066" Name="Myoclonus" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

